Calcium MCHA is a bioavailable source of calcium with scientific support for bone and teeth health. 40 patients at risk of osteoporosis were studied to prevent the appearance or progression of osteoporosis: 32 patients were treated with 6 to 8 g MCHA for 12 months and 8 served as an untreated control group. 68% of the patients had back pain prior to the trial. Of 19 patients with initial back pain only 2 still reported any pain at all after 12-months’ MCHA treatment. In the 8-person control group, back pain severity increased during the trial in 3 patients and was unchanged in the fourth. The MCHA group also had less progression of osteoporosis markers compared to the control group.
The researchers concluded:
“In the MCHA-treated group, there was a dramatic reduction in pain during the trial, almost to the point of its disappearance.”